American Heart Association

  52
  0


Final ID: Sa1060

Gut Microbiota Modulation by Immunosuppression and Cardiac Cell Therapy in a Nonhuman Primate Ischemia/Reperfusion Model of Cardiac Regeneration

Abstract Body (Do not enter title and authors here): End-stage ischemic heart disease necessitates heart transplantation, and emerging cell therapy presents a promising solution to address donor scarcity. Disruption of gut microbiota significantly influences various diseases and treatments, including transplantation. However, the impact of immunosuppression and cardiac cell therapy on gut microbiota remains largely unexplored. To elucidate this relationship, we investigated gut microbiota dynamics in response to immunosuppression and cell therapy in a nonhuman primate (NHP) cardiac ischemia/reperfusion (IR) model, with controlled genetic, dietary, and environmental factors. Immunosuppression enriched anaerobes (Faecalibacterium, Streptococcus, Anaerovibrio, Dialister), increasing gut microbiota diversity. These changes correlated with metabolic shifts towards amino acid metabolism and nucleosides/nucleotides biosynthesis. Combined treatment of human induced pluripotent stem cell (iPSC)-derived endothelial cells (EC) and cardiomyocytes (CM) also increased gut microbiota diversity, with specific genera alterations. The EC/CM co-treatment group displayed gut microbiota resembling the pre-injury group, with host metabolism shifting towards amino acid and fatty acid/lipid biosynthesis post-cell therapy. These observed microbiota changes and metabolic shifts could serve as biomarkers for monitoring cell therapy and immunosuppression outcomes, offering potential therapeutic targets to enhance efficacy.
  • Hsieh, Patrick  ( ACADEMIA SINICA , Taipei City , Taiwan )
  • Author Disclosures:
    Patrick Hsieh: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Inflammation in Cardiovascular and Metabolic Disease

Saturday, 11/16/2024 , 02:00PM - 03:00PM

Abstract Poster Session

More abstracts on this topic:
Constitutive mTORC1 Activation in Macrophages Lacking TSC2 Enhances GPNMB to Ameliorate Cardiac Ischemia-Reperfusion Injury

Keykhaei Mohammad, Koleini Navid, Meddeb Mariam, Tajdini Masih, Farshidfar Farnaz, Rezaee Malihe, Ranek Mark, Kass David

A Heart Transplant Patient’s Mysterious Illness: A Diagnostic Odyssey

Alkalbani Mutaz, Nayer Hassan, Cochrane Adam, Saeed Ibrahim, Psotka Mitchell, Rollins Allman, Kennedy Jamie, Blumer Vanessa

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available